Global Dystrophin Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS12200 | Category: Biotechnology and Life Sciences | Pages: 118 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Dystrophin, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dystrophin.

The Dystrophin market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Dystrophin market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dystrophin manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Dystrophin market size in 2022 is 1460.0 million US dollars, and it is expected to be 20252.7 million US dollars by 2029, with a compound annual growth rate of 45.60% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Dystrophin market include PTC Therapeutics, Sarepta Therapeutics, BioMarin Pharmaceutical Inc, Wave Life Sciences, and Bristol-Myers Squibb and Catabasis. The share of the top 3 players in the Dystrophin market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Dystrophin market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Exondys51 accounted for XX% of Dystrophin market in 2022. Translarna share of XX%.
Exon Skipping accounted for XX% of the Dystrophin market in 2022. Anti-Inflammatory Therapy accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, and global Dystrophin market status and forecast by region.
Chapters 2-3: Segmented the global Dystrophin market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 4: Analysis of the competitive environment of Dystrophin market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Dystrophin market country segmentation data.
Chapter 10: Analyzes the main companies in the Dystrophin industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 12: The main points and conclusions of the report.
Chapter 13: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
PTC Therapeutics
Sarepta Therapeutics
BioMarin Pharmaceutical Inc
Wave Life Sciences
Bristol-Myers Squibb and Catabasis

Types list
Exondys51
Translarna
Emflaza
Others

Application list
Exon Skipping
Anti-Inflammatory Therapy
Stop Codon Read-Through
Others Approaches

Table of Content

1 Dystrophin Market Overview
1.1 Dystrophin Product Overview
1.1.1 Dystrophin Product Scope
1.1.2 Dystrophin Market Status and Outlook
1.2 Global Dystrophin Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Dystrophin Market Size by Region (2018-2029)
1.4 Global Dystrophin Historic Market Size by Region (2018-2023)
1.5 Global Dystrophin Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Dystrophin Market Size (2018-2029)
1.6.1 North America Dystrophin Market Size (2018-2029)
1.6.2 Europe Dystrophin Market Size (2018-2029)
1.6.3 Asia-Pacific Dystrophin Market Size (2018-2029)
1.6.4 Latin America Dystrophin Market Size (2018-2029)
1.6.5 Middle East & Africa Dystrophin Market Size (2018-2029)
2 Dystrophin Market Overview by Type
2.3 Global Dystrophin Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Dystrophin Historic Market Size by Type (2018-2023)
2.5 Global Dystrophin Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Dystrophin Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Dystrophin Market Size Breakdown by Type
2.6.3 Asia-Pacific Dystrophin Market Size Breakdown by Type
2.6.4 Latin America Dystrophin Market Size Breakdown by Type
2.6.5 Middle East and Africa Dystrophin Market Size Breakdown by Type
3 Dystrophin Market Overview by Application
3.3 Global Dystrophin Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Dystrophin Historic Market Size by Application (2018-2023)
3.5 Global Dystrophin Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Dystrophin Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Dystrophin Market Size Breakdown by Application
3.6.3 Asia-Pacific Dystrophin Market Size Breakdown by Application
3.6.4 Latin America Dystrophin Market Size Breakdown by Application
3.6.5 Middle East and Africa Dystrophin Market Size Breakdown by Application
4 Dystrophin Competition Analysis by Players
4.1 Global Dystrophin Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dystrophin as of 2022)
4.3 Date of Key Players Enter into Dystrophin Market
4.4 Global Top Players Dystrophin Headquarters and Area Served
4.5 Key Players Dystrophin Product Solution and Service
4.6 Competitive Status
4.6.1 Dystrophin Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Dystrophin Market Segment by Country
5.1 North America Dystrophin Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Dystrophin Market Segment by Country
6.1 Europe Dystrophin Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Dystrophin Market Segment by Country
7.1 Asia-Pacific Dystrophin Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Dystrophin Market Segment by Country
8.1 Latin America Dystrophin Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Dystrophin Market Segment by Country
9.1 Middle East & Africa Dystrophin Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  PTC Therapeutics
10.1.1 PTC Therapeutics Information
10.1.2 Business Overview
10.1.3 PTC Therapeutics Dystrophin Revenue, Gross Margin
10.1.4 Dystrophin Products Offered
10.1.5 PTC Therapeutics Recent Development
10.2  Sarepta Therapeutics
10.2.1 Sarepta Therapeutics Information
10.2.2 Business Overview
10.2.3 Sarepta Therapeutics Dystrophin Revenue, Gross Margin
10.2.4 Dystrophin Products Offered
10.2.5 Sarepta Therapeutics Recent Development
10.3  BioMarin Pharmaceutical Inc
10.3.1 BioMarin Pharmaceutical Inc Information
10.3.2 Business Overview
10.3.3 BioMarin Pharmaceutical Inc Dystrophin Revenue, Gross Margin
10.3.4 Dystrophin Products Offered
10.3.5 BioMarin Pharmaceutical Inc Recent Development
10.4  Wave Life Sciences
10.4.1 Wave Life Sciences Information
10.4.2 Business Overview
10.4.3 Wave Life Sciences Dystrophin Revenue, Gross Margin
10.4.4 Dystrophin Products Offered
10.4.5 Wave Life Sciences Recent Development
10.5  Bristol-Myers Squibb and Catabasis
10.5.1 Bristol-Myers Squibb and Catabasis Information
10.5.2 Business Overview
10.5.3 Bristol-Myers Squibb and Catabasis Dystrophin Revenue, Gross Margin
10.5.4 Dystrophin Products Offered
10.5.5 Bristol-Myers Squibb and Catabasis Recent Development
11 Dystrophin Market Dynamics
11.1 Dystrophin Industry Trends
11.2 Dystrophin Growth Drivers
11.3 Dystrophin Market Challenges
11.4 Dystrophin Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Dystrophin Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?